PLA2G7 and COVID-19: In COVID-19, knowledge about the etiology and pathophysiology of late complications from acute infection phase is still in its infancy, yet it is known that early and late symptoms are manifestations of a persistent hyper-inflammatory state due to host–viral interactions and inadequate antibody response, which can be better predicted by Lp-PLA2.